Autoimmune & immunology · Phase III

Top sponsors

• Takeda 39 programs
• Janssen-Cilag International N.V 26 programs
• Anaxis Pharma 20 programs
• AbbVie 18 programs
• Novartis India 17 programs
• AbbVie Deutschland GmbH 13 programs
• HOFFMANN-LA ROCHE 11 programs
• Eli Lilly and 9 programs
• Chinese Academy of 8 programs
• Bristol-Myers Squibb Australia 7 programs
• PARItec 7 programs
• Pacira Ireland 7 programs

1. Guselkumab Dose 1

   Janssen Cilag International NV

   Crohn's Disease

   phase 3 · small molecule · active

   1 trial →

2. I4V-MC-JAHU

   Eli Lilly Co.

   Systemic Juvenile Idiopathic Arthritis

   phase 3 · small molecule · active

   1 trial →

3. I4V-MC-JAHX

   Eli Lilly Co.

   Juvenile Idiopathic Arthritis

   phase 3 · small molecule · active

   1 trial →

4. I6T-MC-AMAX

   Eli Lilly Co.

   Crohn’s Disease

   phase 3 · small molecule · active

   1 trial →

5. I6T-MC-AMAY

   Eli Lilly Co.

   Crohn's Disease

   phase 3 · small molecule · active

   1 trial →

6. I6T-MC-AMBA

   Eli Lilly Co.

   Moderately to Severely Active Ulcerative Colitis

   phase 3 · small molecule · active

   1 trial →

7. I6T-MC-AMCD

   Eli Lilly Co.

   Obesity or Overweight, Ulcerative Colitis

   phase 3 · small molecule · active

   1 trial →

8. I6T-MC-AMCE

   Eli Lilly Co.

   Obesity or Overweight, Crohn’s Disease

   phase 3 · small molecule · active

   1 trial →

9. IM011-054

   Bristol-Myers Squibb Australia Pty Ltd

   Active Psoriatic Arthritis

   phase 3 · small molecule · active

   1 trial →

10. IM011-055

    Bristol-Myers Squibb Australia Pty Ltd

    Active Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

11. IM011-075

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate-to-Severe Plaque Psoriasis

    phase 3 · small molecule · active

    1 trial →

12. IM011-1071

    Bristol-Myers Squibb Australia Pty Ltd

    Juvenile Psoriatic Arthritis (JPsA)

    phase 3 · small molecule · active

    1 trial →

13. IM011-1128

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate to Severe Plaque Psoriasis

    phase 3 · small molecule · active

    1 trial →

14. IM047-001

    Bristol-Myers Squibb Australia Pty Ltd

    Moderately to Severely Active Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

15. IM047-023

    Celgene Europe Limited

    Moderately to Severely Active Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

16. IM101-863

    Bristol-Myers Squibb Australia Pty Ltd

    Rheumatoid Arthritis

    phase 3 · small molecule · active

    1 trial →

17. IRIS, D3466C00001

    AstraZeneca AB

    Active Proliferative Lupus Nephritis

    phase 3 · small molecule · active

    1 trial →

18. IV Tulisokibart

    Merck KGaA, Darmstadt, Germany

    Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

19. IV Tulisokibart

    Merck KGaA, Darmstadt, Germany

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

20. Icotrokinra

    Janssen Cilag International NV

    Crohn Disease

    phase 3 · small molecule · active

    1 trial →

21. Icotrokinra, JNJ-77242113-AAC Placebo tablet

    Janssen-Cilag International N.V.

    Moderately to Severely Active Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

22. Infliximab + methotrexate (IFX + MTX)

    Universal Integrated

    Arthritis, Psoriatic

    phase 3 · small molecule · completed

    1 trial →

23. Infliximab Increased Frequency

    Universal Integrated

    Rheumatoid Arthritis

    phase 3 · small molecule · terminated

    1 trial →

24. Intravenous Immunoglobulin

    Option Therapeutics

    Autoimmune Epilepsy

    phase 3 · small molecule · terminated

    1 trial →

25. J2A-MC-GZPT

    Eli Lilly Co.

    Osteoarthritis

    phase 3 · small molecule · active

    1 trial →

26. JNJ-77242113

    Janssen Cilag International NV

    Plaque Psoriasis

    phase 3 · small molecule · active

    1 trial →

27. JNJ-77242113-AAC Placebo tablet, JNJ-77242113

    Janssen-Cilag International N.V.

    Active Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

28. KHK4827

    KYOWA KIRIN AUSTRALIA PTY LTD

    Moderate to Severe Plaque Psoriasis

    phase 3 · small molecule · completed

    1 trial →

29. KYV-101

    Kyverna Therapeutics

    Lupus Nephritis, Systemic Sclerosis, Myasthenia Gravis, Rheumatoid Arthritis, Stiff Person Syndrome

    phase 3 · small molecule · active

    1 trial →

30. KYV101-006

    Kyverna Therapeutics

    Generalized myasthenia gravis

    phase 3 · small molecule · active

    1 trial →

31. LY2127399

    Eli Lilly and Company

    Systemic Lupus Erythematosus

    phase 3 · small molecule · completed

    1 trial →

32. LY2127399

    Eli Lilly and Company

    Rheumatoid Arthritis

    phase 3 · small molecule · terminated

    1 trial →

33. Lansoprazole and naproxen and aspirin

    Takeda

    Osteoarthritis

    phase 3 · small molecule · completed

    1 trial →

34. Leflunomide Mylan for polymyalgia rheumatica

    Disc Medicine

    polymyalgia rheumatica

    phase 3 · small molecule · active

    1 trial →

35. M10-870

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

36. M1095-PSA-301

    MoonLake Immunotherapeutics

    Psoriatic arthritis

    phase 3 · small molecule · active

    1 trial →

37. M1095-PSA-302

    MoonLake Immunotherapeutics

    psoriatic arthritis

    phase 3 · small molecule · active

    1 trial →

38. M14-533

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

39. M14-671

    AbbVie Deutschland GmbH & Co. KG

    Crohn's Disease (CD)

    phase 3 · small molecule · active

    1 trial →

40. M14-682

    AbbVie Deutschland GmbH & Co. KG

    juvenile idiopathic arthritis

    phase 3 · small molecule · active

    1 trial →

41. M15-998

    AbbVie Deutschland GmbH & Co. KG

    Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

42. M16-000

    AbbVie Deutschland GmbH & Co. KG

    Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

43. M16-011

    AbbVie Deutschland GmbH & Co. KG

    Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

44. M16-066

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

45. M16-194

    AbbVie Deutschland GmbH & Co. KG

    Crohn's disease

    phase 3 · small molecule · active

    1 trial →

46. M19-751

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

47. M23-732

    AbbVie Deutschland GmbH & Co. KG

    Juvenile Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

48. M25-540

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions